Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

781.49
-11.7700-1.48%
Pre-market: 780.00-1.4900-0.19%04:01 EDT
Volume:443.99K
Turnover:347.80M
Market Cap:80.46B
PE:19.33
High:800.22
Open:800.00
Low:780.81
Close:793.26
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.80
T/O Rate:0.45%
Dividend:3.64
Dividend Rate:0.47%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.54
PE(LYR):18.84

Loading ...

Morgan Stanley Adjusts PT on Regeneron Pharmaceuticals to $758 From $730, Keeps Equalweight Rating

MT Newswires Live
·
Jul 31

Regeneron Pharmaceuticals Inc : JP Morgan Raises Target Price to $900 from $850

THOMSON REUTERS
·
Jul 31

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 31

Dexcom Q2 Revenue Beats Estimates Raises Outlook; Raises FY Revenue and Margin Guidance

Reuters
·
Jul 31

Stock Track | Regeneron Pharmaceuticals Soars 5.79% in Intraday Trading After Q2 Earnings Crush Estimates on Dupixent and Eylea HD Strength

Stock Track
·
Jul 31

Regeneron Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

U.S. Stocks on the MOVE-Mastercard, Starbucks, Meta

Reuters
·
Jul 30

Movement Alert|Regeneron Pharmaceuticals Rises 3.19% in Regular Trading, Q2 Earnings Massively Beat Expectations

Market Focus
·
Jul 30

Regeneron Pharmaceuticals Shares up 1% After Upbeat Q2 Results

THOMSON REUTERS
·
Jul 30

Sanofi Expects Moderate Increases in R&D Spend

Reuters
·
Jul 30

Regeneron Publishes Corporate Presentation Highlighting Q2 Pipeline Progress and Product Sales Trends

Reuters
·
Jul 30

Regeneron Beats Quarterly Estimates on Eczema Drug Strength, Shares Rise

Reuters
·
Jul 30

U.S. Stocks on the MOVE-Fortinet, Regeneron, Cigna

Reuters
·
Jul 30

Sanofi CEO, on Regeneron Partnership, Says Co's Main Objective Has Been to Rebuild Trust

THOMSON REUTERS
·
Jul 30

Drug Maker Regeneron Gains After Upbeat Q2 Results

Reuters
·
Jul 30

Regeneron Posts Higher 2Q Revenue, Sees Improving Profit

Dow Jones
·
Jul 30

Stock Track | Regeneron Pharmaceuticals Soars 5.69% in Pre-market as Q2 Earnings Blow Past Estimates

Stock Track
·
Jul 30

Regeneron Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Jul 30

Regeneron Q2 Revenue Beats on Higher Dupixent, Eylea HD Sales

Reuters
·
Jul 30

Regeneron Q2 Adjusted EPS USD 14.29 Vs. IBES Estimate USD 10.3

Reuters
·
Jul 30